CTOs on the Move

BridgeHealth

www.bridgehealth.com

 
BridgeHealth connects people with the nation`s best surgical care for a better experience, better outcomes, and better value. We offer a value-based approach to surgical care for self-insured plan sponsors and their members, saving them an average of 30% to 50% on procedures compared with PPO rates. BridgeHealth`s nationwide Centers of Excellence focus on quality outcomes and provide pre-negotiated bundled case rates for a broad scope of surgical procedures, including musculoskeletal, neurological, general surgery, cardiac, bariatric, and women`s health. BridgeHealth contracts with hospital providers who rank in the top quartile for their clinical specialty, based on outcomes and other objective ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Kris Jamsa
Chief Technology Officer Profile

Funding

BridgeHealth raised $40M on 10/22/2020

Similar Companies

Advantage Medical Systems Inc

Advantage Medical Systems Inc is a Lake Mary, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Radeas

Radeas is a clinical laboratory that offers testing for toxicology, COVID-19, PGX, UTI, and blood. They provide timely and accurate information to help guide decisions and ensure improved outcomes, with excellent customer service and a broad network of...

DJO Surgical

DJO Surgical is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Axiom Fitness

Four premier health clubs in the Treasure Valley. Each facility features state of the art equipment, classes for all levels, friendly staff, professional fitness trainers, and flexible hours to help you reach your true potential through health and fit...

Avexis Inc

AveXis is a clinic-ready, synthetic biology platform company. AveXis has, at its core, a desire to establish unique industry and research alliances which will bring innovative treatments to people with unmet medical needs. Our work in spinal muscular atrophy (SMA), a rare/orphan disease, is our first focus.